Peg L Aspatero 3750IU Injection
Marketer
Hetero Healthcare Limited
Salt Composition
Asparaginase (3750IU)
Overview Peg L Aspatero 3750IU Injection
Asparaginase Pegfilgrastim 3750 IU injection treats specific leukemias and other cancers as directed by your physician. Administration involves injection by a healthcare professional, ideally at the same time daily for optimal efficacy. Dosage and frequency are personalized, dependent on your condition and subject to change. Adhere strictly to your doctor's prescription; incorrect usage or overdose may cause severe adverse reactions. Therapeutic effects might not be immediately apparent; discontinue only under medical guidance. Common side effects include shortness of breath, skin rash, nausea, vomiting, and angioedema. Elevated blood sugar is possible, necessitating regular blood tests to monitor glucose levels, treatment response, and potential side effects. Increased fluid intake is recommended to promote urination, safeguarding kidney function. This medication may compromise the immune system, raising infection risk; effective contraception is crucial during treatment. Pregnant, breastfeeding, or planning pregnancy necessitates prior physician consultation.
Uses of Peg L Aspatero 3750IU Injection
Acute leukemia affecting lymphocytes
Major Benefits of Peg L Aspatero 3750IU Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Peg L Aspatero 3750IU Injection:
- Breathlessness
- Rash
- Vomiting
- Angioedema (swelling of deeper layers of skin)
- Edema (swelling)
- Nausea
- Fatigue
- Increased liver enzymes
- Diarrhea
- Decreased blood pressure
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Low albumin level in blood
- Increased glucose level in blood
- Hives
How to use Peg L Aspatero 3750IU Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Peg L Aspatero 3750IU Injection works:
Asparaginase, an antineoplastic enzyme, disrupts essential metabolic pathways in cancer cells, thus inhibiting their proliferation and promoting their demise.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Peg L Aspatero 3750IU Injection lacks established safety data. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Peg L Aspatero 3750IU Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Medical advice is recommended.
Breast feedingCONSULT YOUR DOCTOR
The administration of Peg L Aspatero 3750IU Injection while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingSAFE
Administering Peg L Aspatero 3750IU Injection typically does not impair driving ability.
KidneySAFE IF PRESCRIBED
The use of Peg L Aspatero 3750IU Injection in individuals with kidney impairment appears to pose minimal risk. Current evidence indicates that dosage modification may be unnecessary for this population. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Peg L Aspartero 3750IU Injection's use in individuals with hepatic impairment. Physician consultation is recommended. Routine monitoring of liver function is advisable during treatment.
What if you forget to take Peg L Aspatero 3750IU Injection :
NA
Facts to Know About Peg L Aspatero 3750IU Injection
| Label | Value |
|---|---|
| Chemical Type | Enzyme |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Other anticancer agents |
3,018 People bought this recently